Добавил:

Sekretar kiopkiopkiop18@yandex.ru Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.

Вуз:

Ростовский Государственный Медицинский Университет

Предмет:

Медицина общая

Файл:

Современные_рекомендации_по_диагностике_и_ведению_тиреоидной_узловой

.pdf

Скачиваний:

Добавлен:

24.03.2024

Размер:

2.39 Mб

Скачать

☆

<<< < Предыдущая 1 2 34 / 44

roid nodules:	USdifferentiation: Multicenter retrospective study. Radiology.
2008;247:762-770.
28.KimEK,ParkCS,ChungWY,etal.Newsonographiccriteria for recom-
mending fne-needle aspiration biopsy of nonpalpable solid nodules of the
thyroid. AJR	Am J	Roentgenol. 2002; 178:687-691.
29. Cappelli C, Castellano M, Pirola I, et al. Thyroid nodule shape suggests
malignancy. Eur J Endocrinol. 2006; 155: 27-31.
30.HorvathE,Majlis S,RossiR, et al.An ultrasonogramreporting system
for thyroid nodules stratifying cancer risk for clinical management. J Clin
Endocrinol Metab. 2009; 94:1748-1751.
31. Asteria C, Giovanardi A, Pizzocaro A, et al. US-elastography in the
differential diagnosis of benign and malignant thyroid nodules. Thyroid. 2008;
18:523-531.
32. Tranquart F, Bleuzen A, Pierre-Renoult P, Chabrolle C, Sam Giao M,
Lecomte P. Elastosonography of thyroid lesions [article in French]. J Radiol.
2008;89:35-39.
33. Cosgrove D. Future prospects for SonoVue and CPS. Eur Radiol. 2004;
14(Suppl 8):P116-P124.
34. Rago T, Santini F, Scutari M, Pinchera A, Vitti P. Elastography: New
developments in ultrasound for predicting malignancy in thyroid nodules.
ClinEndocrinol Metab. 2007; 92:2917-2922.
35. Wu HH, Jones JN, Osman J. Fine-needle aspiration cytology of the thy-
roid: Ten years experience in a communityteaching hospital. Diagn Cytopathol.
2006; 34:93-96.				Art	and	Science	of
36. DeMay RM. Thyroid. In: The
Cytopathology. Vol		II:	Aspiration	Cytology.Chicago, IL:ASCPPress,
1996: 703-778.

37. Danese D, Sciacchitano S, Farsetti A, Andreoli M, Pontecorvi A. Di- agnosticaccuracyofconventionalversussonography-guidedfine-needleaspira- tion biopsy of thyroid nodules. Thyroid. 1998; 8:15-21.

38. Deandrea M, Mormile A, Veglio M, et al. Fine-needle aspiration biopsy of the thyroid: comparison between thyroid palpation and ultrasonography. EndocrPract. 2002; 8:282-286.

39. Can AS, Peker K. Comparison of palpation-versus ultrasound-guided fne-needle aspiration biopsies in the evaluation of thyroid nodules. BMC ResNotes. 2008;1:12.

40. BritishThyroidAssociation.Guidelinesforthemanagementofthyroid cancer in adults. London: Royal College of Physicians of London and the British Thyroid Association, 2002 [cited December 1, 2005]. Available at: http://www. british-thyroid association.org/complete%20guidelines.

41. European Federation of Cytology Societies. EFCS; 2007-2009. Fadda
G. SIAPEC	consensus review	[written February 27, 2009;	cited June 2009].
Available at: www.efes.eu.
42. Baloch ZW, LiVolsi VA, Asa SL, et al. Diagnostic terminology and mor-
phologic criteria for cytologic diagnosis of thyroid lesions: A synopsis of the Na-
tional Cancer Institute Thyroid		Fine-Needle Aspiration State of the Science
Conference. Diagn Cytopathol. 2008;36:425-437.
43. Kini SR. Specimen adequacy and assessment, reporting system. In:
Thyroid	Cytopathology: An Atlas and Text. Philadelphia, PA: Lippincott
Williams & Wilkins, 2008: 17-26.
44. Goellner JR, Gharib H, Grant CS, Johnson DA. Fine needle aspiration
cytology of the thyroid, 1980 to 1986. Acta Cytol. 1987;31:587-590.
45.Cersosimo E, Gharib H, Suman VJ, Goellner JR.“Suspicious” thyroid
cytologic fndings: outcome in patients without immediate surgical treatment.
Mayo Clin	Proc. 1993;68:343-348.
46. Gharib H, Goellner JR. Fine-needle aspiration biopsy of thyroid nod-
ules. Endocr Pract. 1995;1:410-417.
47. CarusoD,MazzaferriEL.Fineneedleaspirationbiopsyin the manage-
ment of thyroid nodules. Endocrinologist. 1991;1:194-202.
48.Hamburger JI,HamburgerSW.Fine needle biopsy ofthyroid nodules:
avoiding the pitfalls. N		Y State J Med.1986;86:241-249.
49. Pisani T, Bononi M, Nagar C, Angelini M, Bezzi M, Vecchione A. Fine
needle aspiration and core needle biopsy techniques in the diagnosis of nodular
thyroid pathologies. Anticancer		Res. 2000;20:3843-3847.
50. Renshaw AA, Pinnar N. Comparison of thyroid fne-needle aspiration
and core needle biopsy. A JClinPathol. 2007;128:370-374.
51. Zhang S, Ivanovic M, Nemcek AA Jr, Defrias DV, Lucas E, Nayar R. Thin
coreneedlebiopsycrushpreparationsinconjunctionwithfne-needleaspiration
for the evaluation of thyroid		nodules: a complementary	approach. Cancer.
2008;114:512-518.
52. Elsheikh TM, Singh HK, Silverman JF. Fine-needle aspiration cytology
versuscoreneedlebiopsyintheevaluationofthyroidandsalivaryglandlesions.
Path Case	Rev. 2007;12:3-9.
53. RossDS. Laboratory assessment of thyroid dysfunction.In:RoseBD,
ed. UpToDate. Wellesley, MA: UpToDate, 2005.
54.HegedusL,BonnemaSJ,BennedbaekFN.Managementofsimplenodu-
lar goiter: Current status and future perspectives. Endocr			Rev.2003;24:102-
132. 55. Wallaschofski H, Orda C, Georgi P, Miehle K, Paschke R. Distinction be-
tween autoimmune and non-autoimmune hyperthyroidism			by determination


of TSH-receptor anti-bodies in patients with the initial diagnosis of toxic multi-
nodular goiter. HormMetabRes. 2001;33:504-507.
56. Date J, Feldt-Rasmussen U, Blichert-Toft M, Hegedus L, Graversen HP.
Long-term observation of		serum	thyroglobulin after			resection of nontoxic
goiter and	relation to ultrasonographically demonstrated						relapse. World J
Surg. 1996;20:351-356.
57. Giovanella L, Ceriani L, Ghelfo A, Maffoli M, Keller F. Preoperative un-
detectable serum thyroglobulin in differentiatedthyroidcarcinoma:incidence,
causes and management strategy. Clin Endocrinol					(Oxf). 2007;67:547-551.
58. Cohen R, Campos JM, Salaun C, et al; Groupe d’Etudes des Tumeurs a
Calcitonine (GETC). Preoperative calcitonin levels are predictive of tumor size
andpostoperativecalcitoninnormalizationinmedullarythyroidcarcinoma.Clin
Endocrinol	Metab. 2000;85:919-922.						for diagnosis and
59. Brandi ML, Gagel		RF, Angeli A, et al. Guidelines
therapy of MEN type 1 and type			2.	J Clin Endocrinol Metab. 2001;86:5658-
5671.60. Elisei R, Bottici V, Luchetti F,				et al. Impact	of	routine measurement
of serum calcitonin on the diagnosisand outcome of medullary thyroid cancer:
Experience in 10,864 patients with nodular thyroid disorders. JClin Endocrinol
Metab. 2004;89:163-168.
61.Vierhapper H, RaberW, Bieglmayer C, Kaserer K,WeinhauslA,Nied-
erle B. Routine measurement of plasmacalcitonin in nodular thyroid diseases.
JClinEndocrinolMetab. 1997;82:1589-1593.
62.CheungK,RomanSA,WangTS,WalkerHD,SosaJA.Calcitoninmeasure-
ment in the evaluation of thyroid nodules in the United States: a cost-effective-
ness and decision analysis. J Clin				Endocrinol	Metab.		2008;93:2173-
2180.63. Niccoli P, Wion-Barbot N, Caron P, et al; The French Medullary Study
Group. Interest of routine measurement of serum calcitonin: Study in a large
series of thyroidectomized patients. JClin Endocrinol Metab. 1997;82:338-341.
64. Costante G, Meringolo D, Durante C, Bianchi D, Nocera M, Tumino S, et
al. Predictive value of serum calcitonin levels for preoperative diagnosis of med-
ullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyoid
nodules. JClin Endocrinol Metab. 2007 Feb;92:450-455.
65. Bonnema SJ, Bennedbaek FN, Hegedus L. Danish endocrinologists’
examination and treatment of non-toxic multinodular goiter: a questionnaire
study [article in Danish]. Ugeskr Laeger. 2001;163:1265-1269.
66. Hillenhinrichs H, Emrich D. Euthyroid goiter with							and without func-

tionalautonomyintheeuthyroidphase:acomparison [article inGerman].Nuklearmedizin. 1998;37:95-100.


	67. Tollin SR, Fallon EF, Mikhail M, Goldstein H, Yung E. The utility of thy-
roid nuclear imaging and other studies in the detection and treatment of un-
derlying thyroid abnormalities in patients with endogenous subclinical thyro-
toxicosis. Clin Nucl			Med. 2000;25:341-347.
	68. Krohn K, Wohlgemuth S, Gerber H, Paschke R. Hot microscopic areas
of iodine-defcient			euthyroid goitres contain constitutively activating TSH re-
ceptor mutations. J Pathol. 2000; 192:37-42.
	69. Belfiore A, Sava L, Runello F, Tomaselli L & Vigneri R. Solitary autono-
mously functioning thyroidnodulesand iodinedeficiency. Journal ofClinical En-
docrinology and Metabolism 1996 56 283–287.
	70. Kwak JY, Kim EK, Kim HJ, Kim MJ, Son EJ, Moon HJ. How to combine ul-
trasound and cytological information in decision making about thyroid nodules.
Eur Radiol. 2009; 19: 1923-1931.
	71. Orlandi A, Puscar A, Capriata E, Fideleff H. Repeated fne-needle aspi-
ration of the thyroid in benign nodular thyroid disease: Critical evaluation of
long-term follow-up. Thyroid. 2005; 15:274-278.
	72. Gallo M, Pesenti M, Valcavi R. Ultrasound thyroid nodule measure-
ments: the “gold standard” and its limitations in clinical decision making. En-
docr Pract. 2003; 9:194-199.
Value	73. Menendez Torre E, Pineda Arribas J, Martinez de Esteban JP, et al.
	of repeated		fne needle aspiration cytology in patients with	nodular
goiter. Acta		Cytol. 2007; 51:850-852.
	74. Papini E, Petrucci L, Guglielmi R, et al. Long-term changes in nodular
goiter:a5-yearprospectiverandomizedtrialof levothyroxinesuppressive ther-
apy for benign cold thyroid nodules. J Clin Endocrinol Metab. 1998;83:780-783.
	75. Wemeau JL, Caron P, Schvartz C, et al. Effects of thyroid-stimulating
hormonesuppressionwithlevothyroxineinreducingthevolumeofsolitarythy-
roid nodules and improving extranodular nonpalpable changes: a randomized,
double-blind, placebocontrolled trial by the French Thyroid Research Group. J
Clin Endocrinol Metab. 2002;87:4928-4934.
	76. Hegedus L, Nygaard B, Hansen JM. Is routine thyroxine treatment to
hinder postoperative recurrence of nontoxic goiter justifed? J Clin				Endo-
crinol	Metab. 1999;84:756-760.
	77. Moalem J, Suh I, Duh QY. Treatment and prevention of recurrence of

multinodular goiter: an evidence-based review of the literature. World J Surg. 2008;32:1301-1312.

78.BernadetteBiondi,EmilianoAntonioPalmieri1,MicheleKlain2,Martin Schlumberger3,SebastianoFiletti4andGaetanoLombardiSubclinicalhyperthyroidism:clinicalfeaturesandtreatmentoptionsEuropeanJournalofEndocrinology, Vol 152, Issue 1, 1-9.

79.AuerJA,ScheibnerP,MischeT,LangstegerW,EberO&EberB.Subclinicalhyperthyroidismasariskfactorforatrialfibrillation.AmericanHeartJournal 2001 142 838–842.

80.Hammer J, Johanningmann K, Schatz H & Pfeilschifter J. Subclinical hyperthyroidismisanindependentriskfactorforatrialfibrillationinpatientswith preexistingcardiacdisease.ExperimentalandClinicalEndocrinologyandDiabetes 2001 109 S37.

81.Uzzan B, Campos J, Cucherat M, Nony P, Boissel JP, Perret GY. Effects on bone mass of long term treatment with thyroidhormones:A meta-analysis. Clin Endocrinol Metab. 1996; 81:4278-4289.

82.ParleJV,Maisonneuve P,SheppardMC,BoyleP,FranklynJA.Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: A 10-year cohort study. Lancet. 2001; 358:861-865.

83.La Rosa GL, Lupo L, Giuffrida D, Gullo D, Vigneri R, Belfore A. Levothyroxine and potassium iodide are both effective in treating benign solitary solid cold nodules of the thyroid. Ann Intern Med. 1995; 122:1-8.

84.Miccoli P, Minuto MN, Ugolini C, Pisano R, Fosso A, Berti P. Minimally invasive video-assisted thyroidectomy for benign thyroid disease: An evidencebased review. World J Surg. 2008; 32:1333-1340.

85.AlvaradoR,McMullen T,SidhuSB,DelbridgeLW,Sywak MS.Minimally invasive thyroid surgery for single nodules: an evidence-based review of the lateral mini-incision technique. World J Surg. 2008; 32:1341-1348.

86.Livraghi T, Paracchi A, Ferrari C, et al. Treatment of autonomous thyroid nodules with percutaneous ethanol in-jection: preliminary results: work in progress. Radiology. 1990; 175:827-829.

87.Pacella CM, Bizzarri G, Guglielmi R, et al. Thyroid tissue: US-guided percutaneous interstitial laser ablation: a feasibility study. Radiology. 2000; 217:673-677.

88.Guglielmi R, Pacella CM, Bianchini A, et al. Percutaneous ethanol injection treatment in benign thyroid lesions: role and effcacy. Thyroid. 2004; 14:125-131.

89.ValcaviR,FrasoldatiA.Ultrasound-guidedpercutaneousethanolinjec- tion therapy in thyroid cystic nodules. Endocr Pract. 2004; 10:269-275.

90.Kim JH, Lee HK, Lee JH, Ahn IM, Choi CG. Effcacy of sonographically guided percutaneous ethanol injection for treatment of thyroid cysts versus solid thyroid nodules. AJR Am J Roentgenol. 2003; 180:1723-1726.

91.Zingrillo M, Torlontano M, Chiarella R, et al. Percutaneous ethanol injection may bea defnitive treatment forsymptomaticthyroid cystic nodules not treatable by surgery: Five-year follow-up study. Thyroid. 1999; 9: 763-767.

92.Kim YS, Rhim H, Tae K, Park DW, Kim ST. Radiofrequency abla-

tion of benign cold thyroid nodules: Initial clinical experience. Thyroid.2006;
16:361-367.
93. Spiezia S, Garberoglio R, Milone F, et al. Thyroid nodules and related
symptoms are stably controlled two years after radiofrequency thermal abla-
tion. Thyroid. 2009; 19:219-225.
94. Meier DA, Brill DR, Becker DV, et al; Society of Nuclear Medicine. Pro-
cedure guideline for therapy of thyroid disease with (131) iodine. J Nucl Med.
2002; 43:856-861.
95. Nygaard B, Hegedus L, Nielsen KG, Ulriksen P, Hansen JM. Long-term
effect of radioactive iodine on thyroid function and size in patients with
solitary autonomouslyfunctioning toxic thyroidnodules.ClinEndocrinol(Oxf).
1999; 50:197-202.
96.DietleinM,DresslerJ,GrunwaldF,etal;DeutscheGesellschaftfür Nuk-
learmedizin. Guideline for radioiodine therapy for benign thyroid diseases
(version 4) [article in German]. Nuklearmedizin. 2007; 46:220-223.
97. Bonnema SJ, Bennedbaek FN, Veje A, Marving J, Hegedus L. Propylthi-
ouracil before 131I therapy of hyperthyroid diseases: effect on cure rate evalu-
atedbyarandomizedclinicaltrial.JClinEndocrinolMetab.2004;89:4439-4444.
98.WalterMA,BrielM,Christ-CrainM,etal.Effectsofantithyroiddrugson
radioiodine treatment: systematic review and meta-analysis of randomised
controlled trials. BMJ. 2007; 334:514.
99. Weetman AP. Radioiodine treatment for benign thyroid diseases. Clin
Endocrinol	(Oxf). 2007; 66:757-764.
100. Fast S, Nielsen VE, Bonnema SJ, Hegedus L. Time to reconsider non-
surgical therapy of benign non-toxic multinodular goitre: focus on recombinant
human TSH augmented radioiodine therapy. Eur JEndocrinol. 2009; 160:517-
528. 101. Bonnema SJ, Bertelsen H, Mortensen J, et al. The feasibility of high
dose iodine 131 treatment as an alternative to surgery in patients with a very
large goiter:Effect onthyroid functionand sizeandpulmonary function.JClin
Endocrinol Metab. 1999; 84:3636-3641.
102. Nielsen VE, Bonnema SJ, Hegedus L. The effects of recombinant hu-
man thyrotropin, in normal subjects and patients with goitre. Clin Endocrinol
(Oxf). 2004; 61:655-663.		Boel-Jorgensen H, Grupe P, Hegedus L.
103. Nielsen VE, Bonnema SJ,
Stimulation with 0.3-mg recombinant human thyrotropin prior to iodine 131
therapy to improve the size reduction		of benign nontoxic nodular goiter: a
prospective	randomized double-blind	trial. Arch Intern Med. 2006;166:1476-

1482.104. Silva MN, Rubio IG, Romao R, et al. Administration of a single dose of

recombinanthumanthyrotrophinenhancestheeffcacyofradioiodinetreatment
of large compressive multinodular goitres. Clin Endocrinol (Oxf). 2004; 60:300-
308. 105. Bartolazzi A, Orlandi F, Saggiorato E, et al; Italian Thyroid Cancer
Study Group (ITCSG). Galectin-3-expression analysis in the surgical selection
of follicular thyroid nodules with	indeterminate fne-needle aspiration cytol-
ogy: a prospective multicentre study. Lancet Oncol. 2008; 9:543-549.
106.SalvatoreG,GianniniR,FavianaP, et al.Analysis ofBRAFpointmuta-
tionandRET/PTCrearrangementrefnesthe fne-needle aspiration diagnosis of
papillary thyroid carcinoma. J Clin	Endocrinol Metab. 2004; 89:5175-5180.

107. Yassa L, Cibas ES, Benson CB, et al. Long-term assessment of a multidisciplinary approach to thyroid nodule diagnostic evaluation. Cancer. 2007; 111:508-516.

108. Cobin RH, Gharib H, Bergman DA, et al; ThyroidCarcinoma Task Force. AACE/AAES medical/surgical guidelines for clinical practice: Management of thyroid carcinoma [erratum in: Endocr Pract. 2008;14:802-803]. Endocr Pract. 2001; 7:202-220.

109.CooperDS,DohertyGM,HaugenBR,etal;AmericanThyroidAssociation Guidelines Taskforce. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2006; 16:109-142.

110. Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW, Wiersinga W; European Thyroid Cancer Taskforce. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium [erratum in: Eur Endocrinol. 2006;155:385]. Eur J Endocrinol. 2006; 154:787- 803. 111. Baloch ZW, Barroeta JE, Walsh J, et al. Utility of thyroglobulin measurement in fne-needle aspiration biopsy specimens of lymph nodes in the diagnosis of recurrent thyroid carcinoma. Cytojournal. 2008; 5:1.

112. Kim E, Park JS, Son KR, Kim JH, Jeon SJ, Na DG. Preoperative diagnosis of cervical metastatic lymph nodes in papillary thyroid carcinoma: Comparison of ultrasound, computed tomography, and combined ultrasound with computed tomography. Thyroid. 2008; 18:411-418.

113. Freudenberg LS, Antoch G, Jentzen W, et al. Value of (124)I-PET/ CT in staging of patients with differentiated thyroid cancer. EurRadiol. 2004; 14:2092-2098.

114.AbalovichM,AminoN,BarbourLA,etal.Managementof thyroid dysfunction during pregnancy and postpartum: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2007; 92(Suppl 8):S1-S47.

115.RosenIB,KormanM,WalfshPG.Thyroidnodulardisease in pregnancy: Current diagnosis and management. Clin Obstet Gynecol. 1997; 40:81-89.

116.Moosa M, Mazzaferri EL. Outcome of differentiatedthyroid cancer diagnosed in pregnant women. J Clin Endocrinol Metab. 1997; 82:2862-2866.

117.RallisonML,DobynsBM,KeatingFRJr,RallJE,TylerFH.Thyroidnodularity in children. JAMA. 1975; 233:1069-1072.

118.HungW.Nodularthyroiddiseaseandthyroidcarcinoma.PediatrAnn. 1992; 21:50-57.

119.Niedziela M. Pathogenesis, diagnosis and management of thyroid nodules in children. Endocr Relat Cancer. 2006; 13:427-453.

120.Raab SS, Silverman JF, Elsheikh TM, Thomas PA, Wakely PE. Pediatric thyroid nodules: Disease demographics and clinical management as determined by fne needle aspiration biopsy. Pediatrics. 1995; 95:46-49.

121.Amrikachi M, Ponder TB, Wheeler TM, Smith D,Ramzy I. Thyroid fine-needle aspiration biopsy in childrenandadolescents:experiencewith218 aspirates. DiagnCytopathol. 2005; 32:189-192.

122.Chang SH, Joo M, Kim H. Fine needle aspiration biopsy of thyroid nodules in children and adolescents. J Korean Med Sci. 2006; 21:469-473.

123.Belfore A, La Rosa GL, Padova G, Sava L, Ippolito O, Vigneri R. The frequency of cold thyroid nodules and thyroid malignancies in patients from an iodine-defcient area. Cancer. 1987; 60:3096-3102.

124.NiedzielaM,BreborowiczD,TrejsterE,KormanE.HotnodulesinchildrenandadolescentsinwesternPolandfrom1996 to 2000:Clinical analysis of 31 patients. Pediatr Endocrinol Metab. 2002;15:823-830.

125.Frasoldati A, Pesenti M, Gallo M, Caroggio A, Salvo D, Valcavi R. Diagnosis of neck recurrences in patients with differentiated thyroid carcinoma. Cancer. 2003; 97:90-96.

126.Weber AL, Randolph G, Aksoy FG. The thyroid and parathyroid glands: CT and MR imaging and correlation with pathology and clinical findings. Radio CliNorth Am 2000; 38:1105-1129.